X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

U.S. News & World Report Unveils the 2025-2026 Best Companies to Work For: Private Companies

wn.com - 01/Jul 12:59

The latest ratings spotlight private companies that meet employee needs best across 14 industries, including Aerospace and Defense, IT and Health...

Sorry! Image not available at this time

U.S. News & World Report Unveils the 2025-2026 Best Companies to Work For: Private Companies

wn.com - 01/Jul 12:59

The latest ratings spotlight private companies that meet employee needs best across 14 industries, including Aerospace and Defense, IT and Health...

Sorry! Image not available at this time

Zacks Industry Outlook Highlights Wabtec, Air Lease and The Greenbrier Companies

zacks.com - 01/Jul 13:13

WAB, AL, and GBX stand out in the transport leasing space with rising earnings, buybacks, and dividend growth despite macro headwinds.

Sorry! Image not available at this time

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

zacks.com - 30/Jun 12:30

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold.

Sorry! Image not available at this time

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

zacks.com - 30/Jun 12:30

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold.

Sorry! Image not available at this time

Small Fiber Neuropathy Market Growth Projections 2023-2032: DelveInsight Analysis | Grünenthal, Averitas Pharma, Daiichi Sankyo, ...

wn.com - 11/Jul 16:18

The Key Small Fiber Neuropathy Companies in the market include - Vertex Pharmaceuticals, Grünenthal, Averitas Pharma, Daiichi Sankyo, Helixmith,...

Sorry! Image not available at this time

Indian IT Sector To Witness Soft Growth In Q1 Despite Seasonal Strength: Report

zeenews.india.com - 09/Jul 02:52

The financial service firm sees some sort of modification in Infosys’s FY26 sales growth guidance and soft growth in the top six large-cap IT...

Sorry! Image not available at this time

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

zacks.com - 01/Jul 22:00

Vertex Pharmaceuticals (VRTX) reached $452.16 at the closing of the latest trading day, reflecting a +1.56% change compared to its last close.

Les derniers communiqués